Company intelligence / Profile preview

S S TRANS

Ownership: Private
Development stage: Other

Overview

SS Pharma specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates with a global footprint. The company leverages generative AI to enhance R&D and production processes. It holds multiple international certifications including WHO-GMP and ISO standards. No specific clinical trial results are reported as it primarily serves as a manufacturer for other pharma companies.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on S S TRANS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S S TRANS.

Explore the full profile